Humana, Inc. Hits New 52-Week High at USD 365.06

Humana, Inc., a prominent player in the healthcare services industry, has reached a significant milestone by hitting a new 52-week high of USD 365.06 on June 9, 2026. This achievement underscores the company's robust market position within the mid-cap sector, where it boasts a market capitalization of USD 32,156 million. Over the past year, Humana's stock has demonstrated a performance increase of 3.96%, contrasting with the S&P 500's performance of 22.99%. The company's price-to-earnings (P/E) ratio stands at 27.00, reflecting its valuation in relation to earnings. Additionally, Humana offers a dividend yield of 1.60%, providing a return to its shareholders. With a debt-to-equity ratio of -0.42, Humana maintains a strong balance sheet, while its return on equity is reported at 6.81%. The stock's price-to-book ratio is 1.82, indicating its valuation relative to its book value. The previous 52-week low for Humana was recorded at USD 163.11, highlighting the significant upward movement in its stock price.